drugset / Trial / NCT03147599
Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders
RandomizedParallel-groupSingle-blindTreatment
Summary
A randomized controlled trial to assess clinically the efficacy of the selective ileum spasmolytic mebeverine on daytime incontinence and nocturnal enuresis of orthotopic w-ileal neobladders and quality of life effect within 1 year post-surgery.
Timeline
- Start
- 2017-05-15
- Primary completion
- 2019-05-01
- Completion
- 2019-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Coloverin | Unknown | 135 mg | — |